Navigation Links
Daiichi Sankyo ha completato l'arruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
Date:10/30/2012

la cascata della coagulazione.  

"Siamo lieti di annunciare il completamento del reclutamento dei pazienti  per lo studio Hokusai-VTE, il più ampio studio clinico di questo tipo ed attendiamo i primi risultati nel corso del 2013", ha dichiarato Glenn Gormley, direttore globale della Divisione Ricerca & Sviluppo e Senior Executive Officer Daiichi Sankyo.

Il programma globale di trial clinici per edoxaban include due studi di fase 3: Hokusai-VTE e ENGAGE AF-TIMI 48 (Efficace aNticoaGulazione con fattore xA di ultima GEnerazione nella Fibrillazione Atriale).

Hokusai-VTE

Hokusai-VTE è il più ampio studio clinico internazionale di fase 3, randomizzato, in doppio cieco e double dummy, a gruppi paralleli, che studia edoxaban in monosomministrazione giornaliera  per il trattamento e la prevenzione delle Tromboembolie venose ricorrenti (TEV) in pazienti con trombosi venosa profonda (TVP) e/o embolia polmonare (EP) sintomatiche.

Lo studio, che coinvolge più di 8.250 pazienti in 400 centri di ricerca in 38 stati nel mondo, deriva il suo nome dall'artista e pittore giapponese Katsushika Hokusai.

ENGAGE AF-TIMI 48

ENGAGE AF-TIMI 48 è uno studio clinico internazionale di fase 3, randomizzato, in doppio cieco e double dummy, a gruppi paralleli, che studia l'efficacia e la sicurezza di edoxaban versus warfarin nella prevenzione degli eventi di ictus ed embolia sistemica (SEE) in pazienti con fibrillazione atriale non valvolare. ENGAGE AF-TIMI 48 è il più grande studio sulla fibrillazione atriale (FA), includendo più di 20.500 pazienti in 46 Paesi e più di 1000 centri di ricerca.

La tromboembolia venosa  

TEV è il termine che descrive la formazione di coaguli ematici all'interno di una vena o il successivo distacco del coagulo in un'arteria polmonare. La trombosi venosa profonda (
'/>"/>

SOURCE Daiichi-Sankyo
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Daiichi Sankyo, Inc. Receives FDA Approval to Package Product at New Facility in Bethlehem, PA
2. Daiichi Sankyo Completes Enrolment in Hokusai - VTE, investigating once-daily Edoxaban in the Largest Single Phase 3 Study for the Treatment and Prevention of Recurrence of VTE
3. Anthony Creed Joins DDSTUDIO As GM, Experience Design
4. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
5. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
6. Ampio Pharmaceuticals Schedules 2012 Update Webcast
7. Four-Time Triathlon World Champion Melanie McQuaid Selects Polar USA as Official Heart Rate Training Solution
8. Ampios CEO and CSO Send Message to Shareholders
9. Ampio Pharmaceuticals Announces Proposed Public Offering
10. Ampio Pharmaceuticals Announces Pricing of Public Offering of 4,615,400 Shares of Common Stock
11. Ampio Pharmaceuticals Announces Exercise of Over-Allotment Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014 /PRNewswire-iReach/ -- VAPETEK™, ... a vegetable-glycol solution for use in portable vaporizers, ... the active ingredients in cannabis, cannabidiol offers consumers ... vaporizer devices, and other vaporizer technology. ... Cannabis naturally contains 483 different compounds which are ...
(Date:7/11/2014)... CHAPEL HILL, N.C. , July 11, 2014 ... component of pharmaceutical marketing and, consequently, organizations are ... specifically for patients. As part of ... learned it,s important to educate, communicate and engage ... from disease awareness to patient empowerment. By mapping ...
(Date:7/11/2014)... July 11, 2014 The consumer marketing ... across industry sectors to better identify winning tools ... to engage with and understand consumers, as new ... make critical purchasing decisions. According ... LLC, one area where organizations can observe a ...
Breaking Medicine Technology:VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2New Technologies Transforming Consumer Marketing Research Playbook 2
(Date:7/13/2014)... 13, 2014 Recently, 2014QuinceaneraDresses.com, the ... unveiled its new range of gorgeous Quinceanera ... the demand for elegant Quinceanera outfits is huge. ... items. All the company’s newly released dresses are ... are all elegant and vivid. , It ...
(Date:7/13/2014)... Recently, MyDressCity.com, one of the most popular ... has released its new range of elegant Quinceanera ... available at discounted prices. Worldwide clients can enjoy this ... the company’s online shop, there are plenty of beautiful ... with great materials. MyDressCity.com’s hot items are prom gowns, ...
(Date:7/13/2014)... Epidemiologists forecast an increase in the diagnosed incident ... incident cases in 2013 to 11,568 diagnosed incident cases ... 4.35%, during the forecast period. In 2023, the US ... of aGVHD in the 6MM, with 4,989 diagnosed incident ... diagnosed incident cases of aGVHD, with 704 diagnosed incident ...
(Date:7/13/2014)... A decreased ability to identify odors might ... disease, while examinations of the eye could indicate ... Alzheimer,s, in the brain, according to the results ... Alzheimer,s Association International Conference 2014 (AAIC 2014) in ... decreased ability to identify odors was significantly associated ...
(Date:7/13/2014)... 13, 2014 Wright & Schulte LLC ... been scheduled in July of 2015, in U.S. District ... are in the discovery process in the South ... is presiding over the multidistrict litigation (MDL). The complaints ... of individuals who allege that they took the statin ...
Breaking Medicine News(10 mins):Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2Health News:Cheap Elegant Quinceanera Dresses Unveiled by MyDressCity.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 3Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 4Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 2Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 3Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 4
... of Dental Experts to Advance the , Art, ... April 22 Milestone Scientific Inc. (OTC Bulletin ... technologies, today announced that the Company will be ... Anesthetic Delivery (C-CLAD) in Amelia Island, Florida. ...
... Delaying Retirement SAN MATEO, Calif., April 22 According ... approximately forty-five percent of adult children who are caring ... with two-thirds more concerned about their parents, financial situation ... one of many garnered from a new research study ...
... by UHC and Novation for Outstanding Service-NAPERVILLE, Ill., April ... the healthcare industry,s leading contracting services company, announced ... OMX ), a leader in office products ... Service Excellence Supplier Award most notably as Supplier of ...
... a national team of researchers led by Mayo Clinic ... associated with a significantly lower colorectal cancer risk. However, ... unclear. , The study, being presented at the AACR ... possible links between estrogen exposure and colon cancer molecular ...
... study, led by Lucy Selman and colleagues from King,s ... diseases and their family carers in sub-Saharan Africa often ... and its management, which impacts negatively on their ability ... have been published online by the BMJ ...
... Promoting Health and Wellness and Reducing Common and Costly ... Group Says to Senate and House LeadershipWASHINGTON, April 22 ... Fight Chronic Disease (PFCD) - an organization representing some ... today called on leaders in Congress to encourage updates ...
Cached Medicine News:Health News:Milestone Scientific Hosts Second Annual Symposium on Computer-Controlled Local Anesthetic Delivery (C-CLAD) 2Health News:Milestone Scientific Hosts Second Annual Symposium on Computer-Controlled Local Anesthetic Delivery (C-CLAD) 3Health News:After the Crash, Forty-Five Percent of Caring.com Visitors are Providing Financial Support to Aging Parents 2Health News:After the Crash, Forty-Five Percent of Caring.com Visitors are Providing Financial Support to Aging Parents 3Health News:OfficeMax Named the 2009 Recipient of The UHC Service Excellence Supplier Award 2Health News:OfficeMax Named the 2009 Recipient of The UHC Service Excellence Supplier Award 3Health News:Hormone therapy offers potential protective effect against colon cancer in older women 2Health News:Palliative care skills training needed for health-care staff in sub-Saharan Africa 2Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 2Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 3Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 4Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 5Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 6Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 7
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
Medicine Products: